UVA researchers are evaluating a novel CAR T-cell in order to expand this therapy to treat patients with untreatable lymphomas.
Tag: car T cell therapy
CAR T-cell therapy was just approved by the U.S. Food and Drug Administration for commercial use in adult patients with refractory and relapsed lymphoma.